Accredited Wealth Management LLC Takes Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Accredited Wealth Management LLC bought a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 795 shares of the exchange traded fund’s stock, valued at approximately $72,000.

Several other institutional investors also recently bought and sold shares of XBI. Demars Financial Group LLC bought a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at about $280,309,000. BlueCrest Capital Management Ltd bought a new position in SPDR S&P Biotech ETF during the 4th quarter valued at approximately $138,051,000. Mirae Asset Securities USA Inc. lifted its holdings in SPDR S&P Biotech ETF by 66.7% in the 4th quarter. Mirae Asset Securities USA Inc. now owns 1,500,000 shares of the exchange traded fund’s stock worth $135,090,000 after buying an additional 600,000 shares during the period. Bessemer Group Inc. grew its position in shares of SPDR S&P Biotech ETF by 5.7% in the 4th quarter. Bessemer Group Inc. now owns 1,376,834 shares of the exchange traded fund’s stock worth $123,997,000 after buying an additional 73,866 shares during the last quarter. Finally, RA Capital Management L.P. purchased a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $110,615,000.

SPDR S&P Biotech ETF Stock Up 1.2 %

Shares of SPDR S&P Biotech ETF stock opened at $83.50 on Friday. The company has a market cap of $5.30 billion, a PE ratio of 11.47 and a beta of 1.00. The business has a 50 day moving average of $81.66 and a 200 day moving average of $89.92. SPDR S&P Biotech ETF has a 52 week low of $66.66 and a 52 week high of $105.47.

About SPDR S&P Biotech ETF

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Read More

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.